Rheumatology

A Phase 4, 6 week, randomized double blind, multicenter, active controlled trial to evaluate the effects of celecoxib (Celebrex) or naproxen on blood pressure in pediatric subjects with juvenile idiopathic arthritis (IRB# 31282)